{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T07:35:19Z","timestamp":1793432119200,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jgisurgery.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gastrointestinal Surgery"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.gassur.2024.04.007","type":"journal-article","created":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T05:52:16Z","timestamp":1712555536000},"page":"1185-1193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Prophylaxis and treatment of peritoneal carcinomatosis of gastric origin using hyperthermic intraperitoneal chemotherapy: a systematic review and meta-analysis of randomized trials"],"prefix":"10.1016","volume":"28","author":[{"given":"Mauro","family":"Stefano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6828-9339","authenticated-orcid":false,"given":"Daniele","family":"Perrina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Vallicelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Ansaloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Fugazzola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Coccolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanni","family":"Agnoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni Luca","family":"Frassineti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Passardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Tamberi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Framarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Tassinari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Matteucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Sturaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziana","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto","family":"Catena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.gassur.2024.04.007_bib1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.giec.2021.03.001","article-title":"Gastric cancer epidemiology","volume":"31","author":"Thrift","year":"2021","journal-title":"Gastrointest Endosc Clin N Am."},{"key":"10.1016\/j.gassur.2024.04.007_bib2","series-title":"Gastric Cancer: the 25-year R-Evolution. Updates in Surgery","first-page":"93","article-title":"Locally advanced gastric cancer: neoadjuvant treatment","author":"Monti","year":"2021"},{"issue":"3","key":"10.1016\/j.gassur.2024.04.007_bib3","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.3748\/wjg.v22.i3.1114","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancer","volume":"22","author":"Seshadri","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.gassur.2024.04.007_bib4","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/ijc.28373","article-title":"Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors","volume":"134","author":"Thomassen","year":"2014","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.gassur.2024.04.007_bib5","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.3390\/jcm11051456","article-title":"HIPEC in peritoneal metastasis of gastric origin: a systematic review of regimens and techniques","volume":"11","author":"Gronau","year":"2022","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.gassur.2024.04.007_bib6","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3390\/cancers11010078","article-title":"Variation in clinical application of hyperthermic intraperitoneal chemotherapy: a review","volume":"11","author":"Helderman","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.gassur.2024.04.007_bib7","unstructured":"Pinto C, Damato A, Petrelli F, Ansaloni L, Deraco M, De Simone M, et al. AIOM Guidelines: tumori peritoneali primitivi e secondari. 2021. Accessed December 31, 2021. Available from: https:\/\/www.aiom.it\/linee-guida-aiom-2021-tumori-peritoneali-primitivi-e-secondari\/."},{"issue":"2","key":"10.1016\/j.gassur.2024.04.007_bib8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.6004\/jnccn.2022.0008","article-title":"Gastric cancer. Version 2.2022, NCCN Clinical Practice Guidelines in Oncology","volume":"20","author":"Ajani","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"issue":"10","key":"10.1016\/j.gassur.2024.04.007_bib9","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.annonc.2022.07.004","article-title":"Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"33","author":"Lordick","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1016\/j.gassur.2024.04.007_bib10","unstructured":"PSOGI. International recommendations for the management of peritoneal metastases. Accessed November 18, 2016. Available from: http:\/\/www.psogi.com\/psogi\/international-recommendations-for-the-management-of-peritoneal-metastases\/."},{"issue":"1","key":"10.1016\/j.gassur.2024.04.007_bib11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/1471-2407-14-183","article-title":"GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase III study","volume":"14","author":"Glehen","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.gassur.2024.04.007_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsu.2021.105906","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"88","author":"Page","year":"2021","journal-title":"Int J Surg"},{"key":"10.1016\/j.gassur.2024.04.007_bib13","doi-asserted-by":"crossref","first-page":"j4008","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.gassur.2024.04.007_bib14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2288-12-9","article-title":"Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves","volume":"12","author":"Guyot","year":"2012","journal-title":"BMC Med Res Methodol"},{"issue":"24","key":"10.1016\/j.gassur.2024.04.007_bib15","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Stat Med"},{"key":"10.1016\/j.gassur.2024.04.007_bib16","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. Cochrane Handbook for Systematic Reviews of Interventions version 6.3. Cochrane, 2022. Accessed December 31, 2021. Available from www.training.cochrane.org\/handbook."},{"key":"10.1016\/j.gassur.2024.04.007_bib17","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.gassur.2024.04.007_bib18","series-title":"R: A language and environment for statistical computing","year":"2021"},{"issue":"2","key":"10.1016\/j.gassur.2024.04.007_bib19","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/1097-0142(19880115)61:2<232::AID-CNCR2820610205>3.0.CO;2-U","article-title":"Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with Mitomycin C","volume":"61","author":"Koga","year":"1988","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.gassur.2024.04.007_bib20","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/BF00348209","article-title":"Continuous hyperthermic peritoneal perfusion for the prevention of peritoneal recurrence of gastric cancer: randomized controlled study","volume":"18","author":"Fujimura","year":"1994","journal-title":"World J Surg"},{"issue":"8","key":"10.1016\/j.gassur.2024.04.007_bib21","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1002\/1097-0142(19940415)73:8<2048::AID-CNCR2820730806>3.0.CO;2-Q","article-title":"Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study","volume":"73","author":"Hamazoe","year":"1994","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.gassur.2024.04.007_bib22","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1200\/JCO.1994.12.5.970","article-title":"Adjuvant intraperitoneal cisplatin chemotherapy does not improve long-term survival after surgery for advanced gastric cancer","volume":"12","author":"Sautner","year":"1994","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.gassur.2024.04.007_bib23","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/(SICI)1097-0142(19990201)85:3<529::AID-CNCR3>3.0.CO;2-9","article-title":"Successful intraperitoneal hyperthermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma","volume":"85","author":"Fujimoto","year":"1999","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.gassur.2024.04.007_bib24","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s00268-001-0067-7","article-title":"Indications for early postoperative intraperitoneal chemotherapy of advanced gastric cancer: results of a prospective randomized trial","volume":"25","author":"Yu","year":"2001","journal-title":"World J Surg"},{"issue":"2","key":"10.1016\/j.gassur.2024.04.007_bib25","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/SLA.0b013e3181b0c80e","article-title":"Extensive intraoperative peritoneal lavage as a standard prophylactic strategy for peritoneal recurrence in patients with gastric carcinoma","volume":"250","author":"Kuramoto","year":"2009","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.gassur.2024.04.007_bib26","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.3892\/etm.2014.1599","article-title":"Effect of neoadjuvant chemotherapy combined with hyperthermic intraperitoneal perfusion chemotherapy on advanced gastric cancer","volume":"7","author":"Cui","year":"2014","journal-title":"Exp Ther Med"},{"issue":"1","key":"10.1016\/j.gassur.2024.04.007_bib27","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1186\/s12885-019-6125-z","article-title":"Prophylactic HIPEC with radical D2 gastrectomy improves survival and peritoneal recurrence rates for locally advanced gastric cancer: personal experience from a randomized case control study","volume":"19","author":"Beeharry","year":"2019","journal-title":"BMC Cancer"},{"issue":"12","key":"10.1016\/j.gassur.2024.04.007_bib28","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1016\/j.ejso.2019.07.030","article-title":"Hyperthermic intraperitoneal chemotherapy in serosa-invasive gastric cancer patients","volume":"45","author":"Reutovich","year":"2019","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"10.1016\/j.gassur.2024.04.007_bib29","article-title":"Effect of early body cavity continuous circulation hyperthermia perfusion chemotherapy combined with systemic chemotherapy (and nursing) on survival rate and serum tumor markers in patients with advanced gastric cancer","volume":"18","author":"Liu","year":"2020","journal-title":"Eur J Inflamm"},{"issue":"7","key":"10.1016\/j.gassur.2024.04.007_bib30","doi-asserted-by":"crossref","first-page":"782","DOI":"10.4251\/wjgo.v12.i7.782","article-title":"Role of prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer","volume":"12","author":"Xie","year":"2020","journal-title":"World J Gastrointest Oncol"},{"issue":"1","key":"10.1016\/j.gassur.2024.04.007_bib31","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s12885-021-07925-2","article-title":"Phase II trial of prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer after curative surgery","volume":"21","author":"Fan","year":"2021","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.gassur.2024.04.007_bib32","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/02656736.2022.2028018","article-title":"A novel method of bedside hyperthermic intraperitoneal chemotherapy as adjuvant therapy for stage-III gastric cancer","volume":"39","author":"Liu","year":"2022","journal-title":"Int J Hyperthermia"},{"issue":"6","key":"10.1016\/j.gassur.2024.04.007_bib33","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1245\/s10434-011-1631-5","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a Phase III randomized clinical trial","volume":"18","author":"Yang","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.gassur.2024.04.007_bib34","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/jso.23633","article-title":"Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: results of the GYMSSA trial","volume":"110","author":"Rudloff","year":"2014","journal-title":"J Surg Oncol"},{"issue":"1","key":"10.1016\/j.gassur.2024.04.007_bib35","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1186\/s12885-021-08872-8","article-title":"Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II\/III adenocarcinoma \u2013 the phase III \u201cPREVENT\u201d-(FLOT9) trial of the AIO\/CAOGI\/ACO","volume":"21","author":"G\u00f6tze","year":"2021","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.gassur.2024.04.007_bib36","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1245\/s10434-021-11316-z","article-title":"Hyperthermic intraperitoneal chemotherapy (HIPEC) combined with surgery: a 12-year meta-analysis of this promising treatment strategy for advanced gastric cancer at different stages","volume":"29","author":"Zhang","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.gassur.2024.04.007_bib37","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s00423-021-02137-5","article-title":"Survival advantage of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced gastric cancer: experience from a Western tertiary referral center","volume":"406","author":"Rosa","year":"2021","journal-title":"Langenbecks Arch Surg"},{"issue":"26","key":"10.1016\/j.gassur.2024.04.007_bib38","doi-asserted-by":"crossref","first-page":"7954","DOI":"10.3748\/wjg.v21.i26.7954","article-title":"Multimodal treatment of gastric cancer in the west: where are we going?","volume":"21","author":"Marrelli","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"12","key":"10.1016\/j.gassur.2024.04.007_bib39","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s00104-022-01699-4","article-title":"Peritoneal carcinomatosis of gastric cancer: treatment options for peritoneal carcinomatosis of gastric cancer","volume":"93","author":"Dobrindt","year":"2022","journal-title":"Chirurgie (Heidelb)"},{"issue":"1","key":"10.1016\/j.gassur.2024.04.007_bib40","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejso.2013.10.019","article-title":"Intraperitoneal chemotherapy in advanced gastric cancer. Meta-analysis of randomized trials","volume":"40","author":"Coccolini","year":"2014","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.gassur.2024.04.007_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2017.03.030","article-title":"The 30-year experience-a meta-analysis of randomised and high-quality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer","volume":"79","author":"Desiderio","year":"2017","journal-title":"Eur J Cancer"},{"issue":"11","key":"10.1016\/j.gassur.2024.04.007_bib42","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1016\/j.ejso.2021.05.016","article-title":"Prognostic impact of cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in gastric cancer patients: a meta-analysis of randomized controlled trials","volume":"47","author":"Granieri","year":"2021","journal-title":"Eur J Surg Oncol"}],"container-title":["Journal of Gastrointestinal Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X24004086?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X24004086?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T13:12:00Z","timestamp":1719925920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091255X24004086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1091255X24004086"],"URL":"https:\/\/doi.org\/10.1016\/j.gassur.2024.04.007","relation":{},"ISSN":["1091-255X"],"issn-type":[{"value":"1091-255X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prophylaxis and treatment of peritoneal carcinomatosis of gastric origin using hyperthermic intraperitoneal chemotherapy: a systematic review and meta-analysis of randomized trials","name":"articletitle","label":"Article Title"},{"value":"Journal of Gastrointestinal Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gassur.2024.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Society for Surgery of the Alimentary Tract. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}